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ABSTRACT 
 
In this work we present the drug release properties and morphological studies of fibers 
formed by mixing different ratios of poly(lactic acid) (PLA) and poly(3-thiophene methyl 
acetate) (P3TMA) loaded with four drugs (ciprofloxacin, chlorhexidine dihydrochloride, 
triclosan and ibuprofen sodium salt). Thus, the main aim of this study is to prove that the 
excellent cellular response of PLA-P3TMA biocompatible scaffolds can be successfully 
combined with essential applications as drug carrier and delivery systems. AFM and SEM 
micrographs of PLA-P3TMA fibers indicate that the presence of the conducting polymer 
inside the PLA matrix affects the surface morphology, resulting in a significant increment of 
the bulk conductivity with respect to PLA fibers. Electrospun hybrid fibers of PLA and 
P3TMA successfully load both hydrophilic and hydrophobic drugs, the release profiles 
depending on the release environment (i.e. the release rate increases with the hydrophobicity 
of the medium). Finally, our results prove that the antibacterial activity of the drugs is not 
affected by their interactions with the PLA-P3TMA matrix. 
 
 
Keywords: Biopolymers, biocomposites; Conducting polymers; Nanotechnology; 
Atomic force microscopy (AFM); Drug delivery systems.  
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1. INTRODUCTION 
Research based on the use of bioplastics and biosolvents for the development of advanced 
materials has increased considerably in the last decade. Poly(lactic acid) (PLA), a 100% 
biodegradable biopolymer, has been extensively investigated and used in different 
commercial and industrial applications, such as automotive parts, clothing and carpet fibers, 
food packaging, among others. PLA can be synthesized by polycondensation from lactic 
acid, which is a renewable resource derived from the starch of either corn of sugar beets that 
is fermented to form glucose and, consequently, converted to lactic acid. Accordingly, PLA 
can be considered as active player in green chemistry as it reduces significantly the carbon 
foot print when compared to other oil based traditional plastics. Furthermore, due to its good 
mechanical integrity, biodegradability and biocompatibility, PLA and its copolymers are 
widely used in biomedical field. Thus, these materials have been employed for the 
fabrication of drug loading and release devices, surgical sutures, and scaffolds for tissue and 
nerve regeneration [1-7].  
On the other hand, electroactive conducting polymers (CPs) represent another important 
family of organic materials with proved biocompatibility [5,8-14]. More specifically, CPs 
have attracted the attention of biomedical engineers because cells respond to external 
electrical and/or electrochemical stimuli in vitro and in vivo when in contact with CPs [12-
14]. Thus, application of external potentials has been found to promote cellular adhesion, 
proliferation, growth and differentiation. For example, Schmidt and co-workers proved that 
neurite length of PC-12 cells cultured on polypyrrol (PPy) films increase more upon the 
application electrical stimuli [15]. These observations suggested that rationally designed 
conducting and electroactive nanoconstructs (e.g. nanomembranes and nanofibers) could act 
simultaneously as scaffolds for tissue engineering and efficient systems for drug targeting 
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and delivery [14-16]. Indeed, CPs are attractive for a number of biomedical applications as 
was reviewed Schmidt and co-workers [19].  
One of the major drawbacks in the use of CPs for biomedical applications is the lack of 
mechanical integrity and restricted processability of many of these materials, combined with 
their non-degradability [5]. Limitations of CPs are frequently overcome by blending these 
materials with biodegradable polymers [5-20]. Albertsson and co-workers have vastly 
studied the combination of biodegradable polymers with CPs for bioengineering 
applications [20]. For example, such group studied the degradability and cytotoxicity of 
blends made of caprolactone and hyperbranched degradable CPs as good candidates for 
neural tissue engineering application [21]. More recently, free standing nanomembranes for 
tissue regeneration were prepared by spin-coating mixtures of polyester [22,23] or 
thermoplastic polyurethane [24] with a soluble polythiophene derivative, poly(3-thiophene 
methyl acetate) (P3TMA). The same approach has also been used to fabricate electroactive 
biodegradable 3D scaffolds. For example, regular microfibers were recently obtained by 
electrospinning a mixture of P3TMA and biodegradable poly(ester urea) [25]. The overall of 
the results obtained in this field proved the synergy associated to the combination of 
biodegradable polymers and CPs, their mixtures showing biodegradability and both 
electrochemical and electrical activities.  
In the last years some studies based on nanofibers made of PLA–CP blends have been 
reported. However, the preparation of such nanoconstructs has been essentially restricted to 
the combination of biodegradable polymer with small electroactive oligomers (e.g. 
oligothiophenes [26] and oligoanilines [27,28], polyaniline (PAni) or PPy derivatives 
[20,29-31]. On the other hand, antecedents on drug delivery systems fabricated with 
nanofibers based on biodegradable polymers–CP blends are very scarce. Martin and co-
workers developed electrospun poly(lactide-co-glycolide)–poly(3,4-
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ethylenedioxythiophene) conductive core-sheath nanofibers (PLGA–PEDOT) able to 
modulate the release of dexamethasone, an anti-inflammatory drug for the central nervous 
system [32]. More recently, we designed and synthesized series of linear micro/nanofibers 
for tissue engineering applications using PLA–P3TMA blends with different compositions 
[33]. Scaffolds containing P3TMA exhibited enhanced cellular proliferation and adhesion in 
comparison to those made of pristine PLA. Such improvement was attributed to the 
electrochemical properties (i.e. ability to exchange ions) and wettability properties provided 
by the CP.  
The objective of the present work is to show the multi-functionality of scaffolds made of 
PLA–P3TMA fibers, which is based on the combination of the already known cellular 
response [33] with their high activity as drug carrier and delivery systems. In order to prove 
this duality, the encapsulation and delivery of different drugs in PLA–P3TMA systems have 
been investigated by controlling both the fiber morphology and the composition of the 
blend. Four drugs have been considered for this purpose: ciprofloxacin (CIP), chlorhexidine 
dihydrochloride (CHX), triclosan (TCS), and ibuprofen sodium salt (IBU). The selection of 
these compounds was based on the fact they are typically considered as models antibiotics 
(CIP), biocides (CHX and TCS) and anti-inflammatories (IBU). 
 
 
2. EXPERIMENTAL SECTION 
2.1. Materials  
3-Thiophene acetic acid (3TAA) (98.0%) was purchased from Fluka (Sigma-Aldrich). 
Iron chloride anhydrous (97.0%), dry methanol (99.5%) and chloroform (99.9%) were 
purchased from Panreac Quimica S.A.U. (Spain) and used as received without further 
purification. PLA, a product of Natureworks (polymer 2002D), was kindly supplied by 
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Nupik International (Polinyà, Spain). According to the manufacturer, this PLA has a D-
lactide content of 4.25%, a residual monomer content of 0.3%, a density of 1.24 g/cc, a glass 
transition temperature (Tg) of 58 ºC, a melting point of 153 ºC and molecular weights of Mn 
= 59,300 g·mol
-1
 and Mw = 117,500 g·mol
-1
. CIP (≥ 98% HPLC), CHX (≥ 98%), TCS 
(irgasan, ≥ 97% HPLC), and IBU (≥ 98% GC) were purchased from Sigma-Aldrich. 
Escherichia coli CECT 101 and Staphylococcus epidermidis CECT 231 bacterial strains 
were obtained from the Spanish Collection of Type Culture (Valencia, Spain), and culture 
media were purchased from Difco (Detroit, MI, USA). 
 
2.2. Synthesis of Poly(3-thiophene methyl acetate) 
 P3TMA was synthesized by chemical oxidative coupling polymerization in dry 
chloroform following the procedure described by Kim et al. [34], which was successfully 
used in previous works [22-25]. Anhydrous ferric chloride (FeCl3) was used as both oxidant 
and dopant. The monomer 3-thiophene methyl acetate (3TMA) was obtained with a 74% 
yield by refluxing 3TAA in dry methanol for 24 hours at a temperature of 90 ºC. P3TMA 
was subsequently prepared by a chemical oxidative coupling polymerization in dry 
chloroform and using anhydrous ferric chloride (FeCl3) was as oxidant and dopant. The 
polymerization yield was ca. 61% after removing the residual oxidant oligomers. Molecular 
weights were estimated by size exclusion chromatography (SEC) using 1,1,1,3,3,3-
hexafluoroisopropanol as eluent. The number and weight average molecular weights found 
were Mn = 10,700 g mol
-1
 and Mw = 22,500 g mol
-1
 for P3TMA. 
1
H-NMR (400MHz, CDCl3) 
δ = 7.28-7.07 (m, 1H, Ar-H), 3.68(s, 2H, -CH2-), 3.63 (s, 3H, O-CH3); 
13
C-NMR (100MHz, 
CDCl3) δ = 170.8 (C=O), 136-124 (Ar-C), 52.1 (O-CH3), 34.3 (CH2); FTIR-ATR (cm
-1
): 
3095-3010 (=C-H β, thiophene ring), 2998 (C-H aliphatic), 1735 (C=O, ester), 1436 (-CH2-
), 1375 (-O-CH3, ester), 1255-1160 (C-O-CH3, ester), 840 (C-H β, thiophene ring).  
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2.3. Preparation of PLA–P3TMA fibers   
For the nanofiber preparation, mixtures of PLA and P3TMA were electrospun from 
chloroform/acetone (2:1 v/v) at polymer concentrations of 5 w/v-% and 0-5 w/v-% for PLA 
and P3TMA, respectively. Samples will be identified indicating the PLA and P3TMA ratio. 
According to our previous optimization of the processing conditions [33], PLA electrospun 
fibers were collected on a target with a deposition distance of 12 cm, applying a voltage of 
20 kV with a portable High Voltage Source (model ES30-5W, Gamma High Voltage 
Research, Ormond Beach (FL), USA) and a flow rate of 4 mL·h
-1
. The voltage and flow-rate 
used to prepare PLA–P3TMA fibers was 25 kV and 4 mL·h-1, respectively). Polymer 
solutions were delivered via a KDS100 infusion syringe pump (code KDS100, KD Scientific 
Inc., Holliston (MA), USA)  to control the mass-flow rate, and the tip used had an inside 
diameter of 0.84 mm (syringe needle 18G). All electrospinning experiments were carried out 
at room temperature. The diameter of the fiber prepared under such conditions ranged from 
600 to 800 nm. 
 
2.4. PLA–P3TMA (2:1 ratio) fibers drug-loading  
PLA (0.5 g) was dissolved in 5 mL of chloroform-acetone mixture (2:1 v/v) and P3TMA 
(0.25 g) in 4 mL of the same solvent mixture. Then, 1 mL of dimethylsulfoxide (DMSO) 
containing the drug (0.1 g) was added, and the mixture was homogenized by vortexing to 
obtain an electrospinable solution of 5 w/v-% PLA, 2.5 w/v-% P3TMA and 1 w/v-% drug. 
The electrospinning process was conducted at room temperature, fibers being collected at a 
distance of 12 cm from the needle (18G, inside diameter of 0.84 mm). The applied voltage 
and the flow rate was of 25 kV and 4 mL·h
-1
, respectively.  
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2.5. Characterization  
1
H-NMR and 
13
C-NMR spectra were acquired with a Bruker AMX-300 spectrometer 
(Bruker Corporation, Billerica (MA), USA) operating at 300.1 MHz. Chemical shifts were 
calibrated using tetramethylsilane as an internal standard. Deuterated chloroform was used 
as the solvent.  
Infrared absorption spectra were recorded with a Fourier Transform FTIR 4100 Jasco 
spectrometer (Jasco Analytical Instruments, Easton, (MD), USA) in the 4000-600 cm
-1
 
range. An attenuated total reflection (ATR) system with a heated Diamond ATR Top-Plate 
(model MKII Golden Gate
TM
, Specac Ltd., Orpington (Kent), UK) was used.  
Atomic force microscopy (AFM) images were obtained for all the samples in tapping 
mode with an AFM Dimension 3100 microscope and a NanoScope® V controller (Veeco 
Instruments Inc., Plainview (NY), USA) at ambient conditions. A silicon probe (model 
Tap150-G, Budget Sensors®, Innovative Solutions Bulgaria Ltd., Sofia, Bulgaria) with a 
resonant frequency and spring constant of 150 kHz and 5 N·m
-1
, respectively, was used. The 
row scanning frequency was set at 0.8 Hz and the scan window size varied from 11 µm2 to 
2020 µm2. Data were acquired using the Reasearch NanoScope software (v. 7.30) and, 
afterwards, they were analyzed using the NanoScope Analysis analysis software (v. 1.20).  
The Root Mean Square (RMS) roughness, which is the average height deviation taken from 
the mean data plane, was determined using the statistical application of the NanoScope  
Analysis software (1.20, Veeco). 
A Confocal Raman-AFM microscope (model a300R+, WITec - Wissenschaftliche 
Instrumente und Technologie GmbH-, Ulm, Germany) was used to collect Raman spectra 
from the homopolymers, PLA–P3TMA blends and drug loaded samples. For excitation, a 
laser with wavelength of 785 nm was used. The integration time was between 0.3 and 2.1 
seconds depending on the scan, and high resolution Raman images were obtained by 
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collecting complete Raman spectra at less than 3 cm
-1
 per pixel. Fibers were analyzed as 
obtained after the electrospining process, without any additional preparation, at room 
temperature and after the exposure time necessary to decay the fluorescence.  
The number-average molecular weight (Mn) and weight-average molecular weight (Mw) 
were measured by gel permeation chromatography (GPC) at 25 °C using a chromatograph 
(model 1525 - Binary HPLC Pump) equipped with a refractive index detector (model 2414) 
from Waters Cromatografía, S.A., (Cerdanyola del Vallès, Spain). GPC measurements were 
carried out using tetrahydrofuran (THF) as eluent with a flow rate of 1.0 mL·min
-1
, 
respectively. Polystyrene standards were used for calibration.  
Optical morphologic observations were performed using Zeiss Axioskop 40 microscope 
(Carl Zeiss Microscopy, LLC, USA). Micrographs were taken with Zeiss AxiosCam MRC5 
digital camera (Carl Zeiss Microscopy, LLC, USA). Morphological characterization of the 
electrospun samples was conducted by scanning electron microscopy (SEM) using a Focus 
Ion Beam Zeiss Neon 40 instrument (Carl Zeiss, Germany). Prior sample observation, 
carbon coating was accomplished by using a Sputter Coater (model Mitec K950, Quorum 
Technologies Ltd., Ashford (Kent), UK) fitted with a film thickness monitor k150. 
Samples were visualized at an accelerating voltage of 5 kV. Diameter of electrospun fibers 
was measured with the SmartTiff software from Carl Zeiss SMT Ltd (Jena, Germany).  
Contact angle (CA) measurements were performed using an OCA 15EC (DataPhysics 
Instruments GmbH, Filderstadt, Germany) equipment and using the droplet sessile method 
at room temperature. Three different polar solvents were tested: ultrapure water, formamide 
and ethylene glycol. For the static contact angle (sCA) measurements, 0.5 μL droplets of 
liquid were dispensed on the respective surfaces. Images were recorded after drop 
stabilization (30 s) using the SCA 20 software. CA values were obtained as the average of 
fourteen independent measures for each sample. The surface energy (SE) of PLA–P3TMA 
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samples was calculated based on the sCA data by applying several mathematical 
approaches: Equation-of-State (EoS), Fowkes, Owens-Wendt-Rabel-Kaelble (OWRK) and 
Wu models. Finally, the work of adhesion (WA) was determined to quantify the wettability 
of a liquid droplet on the sample.  
 
2.6. Electrochemical impedance spectroscopy (EIS). EIS measurements were performed 
using a potentiostat/galvanostat (model AUTOLAB PGSTAT302N, Metrohm AG, Herisau, 
Switzerland) in the 10 kHz to the 10 mHz frequency range and the amplitude of the 
sinusoidal voltage was 10 mV. All experiments were carried at room temperature. The fiber 
mats were cut in a disc format (1.766 cm
2
) and were sandwiched between two stainless steel 
electrodes assembled into an isolating resin holder [35]. The cell was tightened with screws 
to ensure constant pressure fastening. The thickness of the films, which was determined by a 
micrometer, varied between 18.9 and 26.0 μm. Prior cell closing, samples were immersed in 
phosphate buffer saline (PBS, pH 7.4) at room temperature for 24h and the water excess 
wiped out with a tissue. After data collection, EIS results were then processed and fitted to 
an electrical equivalent circuit (EEC). 
 
2.7. Drug-release experiments. Drug-loaded mats were cut into small square pieces 
(20200.1 mm3) which were weighed and placed into polypropylene tubes. PBS and PBS 
supplemented with 70 v/v-% of ethanol (PBS-EtOH) were considered as release media. The 
addition of ethanol to hydrophilic PBS increases the hydrophobicity of the medium and 
provokes some swelling effect, both favoring the release of hydrophobic drugs as TCS [36]. 
The release of TCS from PLA fibers in PBS containing 10 and 70 v/v-% of ethanol was 
found to be 40% and 98% after 48 h, respectively, indicating that the composition of PBS-
EtOH is adequate to alter the equilibrium defined by the affinity of PLA towards 
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hydrophobic drugs [36]. Drug-release assays were carried out by immersing sample mats in 
50 mL of the release medium at 25 ºC for 1 week. Aliquots (1 mL) were drawn from the 
release medium at predetermined intervals, and an equal volume of fresh medium was added 
to the release vessel. The drug concentration in the release medium was evaluated by UV-vis 
spectroscopy (UV-VIS-NIR Spectrophotometer model UV-3600 Plus from Shimadzu 
Corporation, Kyoto, Japan). Calibration curves were obtained by plotting the absorbance 
measured at the corresponding wavelengths (i.e. 322, 254, 281, and 260 nm for CIP, CHX, 
TCS and IBU, respectively) against drug concentration. Finally, the mats were dissolved in 
chloroform and the residual drug was extracted in ethanol for quantification. All tests were 
performed in triplicate to control the homogeneity of the release, and the results were 
averaged.
 
 
2.8. Agar diffusion test. Escherichia coli and Staphylococcus epidermidis were cultured 
aerobically overnight in 15 mL of brain–heart infusion (BHI) broth at 37 ºC. The bacterial 
suspension was spread on Plate Count Agar (PCA) (Difco
TM
 MI Agar, from Becton, 
Dickinson and Company, Franklin Lakes (NJ), USA) using a nylon swab. Uniform disks of 
1 mm thick and 5 mm in diameter were prepared by perforating the drug-loaded PLA–
P3TMA electrospun mats. Then, samples were placed on the surface of the agar plates and 
incubated at 37 ºC. After 24h, the inhibition zone around each specimen was observed to 
determine the activity of the drug. 
 
3. RESULTS AND DISCUSSION 
3.1. Topography and RAMAN analyses of PLA–P3TMA fibers 
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The electrospinning conditions and morphology of PLA–P3TMA fiber mats were 
examined in our previous study [33]. Scanning electron microscopy (SEM) micrographs 
evidenced that the incorporation of P3TMA in the electrospinning solution induced some 
structural changes in the PLA fiber: (1) the fiber diameter decreased slightly; (2) the fiber 
surface became smoother; and (3) heterogeneous clusters made of P3TMA aggregates 
appeared inside the fibers. Furthermore, both the electrochemical activity and the bioactivity 
of the fibers increased with the content of P3TMA.  
AFM analyses (Figure 1) provided more precise information about the roughness of 
electrospun PLA and of PLA–P3TMA fibers. PLA fibers exhibit remarkable irregularities 
on their surface, their average RMS roughness ± 2 times the corresponding standard 
deviation (calculated using five different samples) being 41.4 nm ± 3.8 nm. The average 
RMS roughness determined for 5:1, 2:1 and 1:1 PLA–P3TMA compositions (Figures 1b-d) 
is 34.8 nm ± 2.5 nm, 39.9 nm ± 3.0 nm and 35.6 nm ± 4.5 nm, respectively. AFM phase 
images allow us to distinguish a phase contrast for PLA–P3TMA samples that is not 
observed for the PLA fibers. This supports that the two polymers mixed in the chloroform 
solution successfully incorporate into the electrospun fibers, even though it is not possible to 
associate each region (i.e. dark or bright areas) to a specific polymer-rich phase.  
Further studies were carried out to understand P3TMA compositional distribution on 
PLA-P3TMA fibers by means of Raman spectroscopy. Figure 2a shows optical images 
taken with the Raman confocal microscope of PLA fibers, the Raman spectrum being 
displayed in Figure 2b. As it can be seen, the PLA spectrum presents identifiable peaks at 
well-known positions [37]. The most intense band, which corresponds to the vC-COO 
stretching is located at ca. 874 cm
-1
 (highlighted in Figure 2b). 
Optical images of PLA–P3TMA fibers are displayed in Figures 2c and 2e. P3TMA 
powder was analyzed by Raman spectroscopy and the resulting spectrum is depicted in 
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Figure 2d). As the fluorescence induced by the laser at 532 nm used for PLA fibers is very 
high for P3TMA, CP-containing samples were analyzed using the laser at 785 nm. This 
leaded to less fluorescence overlapping but also to a lower peak resolution. The most intense 
line for the P3TMA spectra is identified at ca. 1480 cm
-1
, which corresponds to the totally 
symmetric in–phase vibration of the thiophene rings spread over the polymer chains [38]. 
Raman spectra were recorded from three different spots of the PLA–P3TMA fibers (Figures 
2c and 2d) as well as from P3TMA particles, which are clearly visible as dark spots inside 
the fibers (Figures 2c and 2e). These results corroborate the homogenous distribution of 
P3TMA among the PLA fibers, even though some CP agglomerates are also detected. 
Moreover, 2:1 PLA–P3TMA fibers loaded with drugs were also evaluated by Raman 
spectroscopy (discussed below). 
 
3.2. Wettability and surface energy determination  
Understanding of the wetting properties of PLA–P3TMA fibers is crucial for their use as 
drug carrier and delivery systems. Two wetting states have been defined for hydrophobic 
surfaces [39]. In the Wenzel state, which corresponds to a homogeneous wetting regime, the 
liquid completely penetrates into the grooves defined by the surface roughness, while air 
bubbles inside the grooves underneath the liquid in the heterogeneous wetting regime 
associated to the Cassie-Baxter state. Air entrapped into 3D fibrous scaffolds may act as a 
barrier precluding water penetration and, therefore, affecting the drug-delivery. However, a 
transition from the Cassie-Baxter state to the Wenzel state may occur whenever air regions 
are no longer thermodynamically stable and liquid infiltrates the surface. Thus, the drug-
delivery rate can be tuned by controlling the wettability of drug-loaded systems [40].  
Table 1 gives the static contact angles (sCA) values of deionized water, formamide and 
ethylene glycol solvents determined for PLA and PLA–P3TMA scaffolds. Results are 
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compared with those obtained for films prepared by solvent-casting a chloroform solution of 
the corresponding blend. As it can be seen, the wetting behavior depends on the 
organization. For each solvent, the sCA of scaffolds made of fiber diameters varying from 
600 to 800 nm is higher than that of films prepared by solvent evaporation for PLA and all 
blend compositions. Hence, the fiber matrix is able to block the liquid phase resulting in a 
less wettable surface (Figure 3), which has been attributed to both the fiber roughness and 
the air entrapped at the surface. In spite of this, the exact final frontier of the three-phase 
contact line (TPCL) is unclear since the liquid may penetrate the porous matrix through the 
space left among adjacent fibers. Therefore, it is not possible to ascertain which state (i.e. 
Wenzel, Cassie-Baxter or the transition them) is the most appropriated to adjust the wetting 
behavior of PLA and PLA–P3TMA fibrous scaffolds. 
Also, sCA values of water and formamide indicate that the incorporation of P3TMA into 
PLA fibers does not provoke significant changes in the wettability of the polyester (Table 1), 
independently of the blend composition. For ethylene glycol, PLA–P3TMA fibers exhibit 
lower wettability than PLA, the CAs increasing of the polyester increasing 13º-20º upon the 
addition of the CP. This is a very attractive result for drug-release applications since the low 
wettability of PLA–P3TMA scaffolds in such solvents is expected to be accompanied by a 
slow release.  
Surface phenomena, like wetting, adsorption and adhesion, are controlled by the surface 
energy (SE) of the materials used for deposition. The sCA values displayed in Table 1 have 
been used to estimate the SE using the Equation-of-State (EoS) [41], Fowkes [42], Owens-
Wendt-Rabel-Kaelble (OWRK) [43,44] theoretical models. As each model considers 
different physical assumptions and interactions for the calculation of the SE components, 
comparison among such approaches is not an easy task. Results derived from the different 
models, which are displayed in Table 2, reveals a general tendency. The SE of the solid-gas 
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interface (S) and its dispersion and polar components (
d
S  and 
p
S , respectively) decrease 
with increasing P3TMA content. Samples with high SE, like PLA fibers, are more readily to 
interact with liquids because of their bonding potential. Results allow us to conclude that a 
small percentage of P3TMA adequately dispersed in the electrospinning process is able to 
reduce the S components, precluding rapid drug release.  
The influence of the fibrous morphology in the SE of PLA and PLA–P3TMA was 
examined by comparing results displayed in Table 2 with those obtained for films prepared 
by solvent casting using chloroform solutions (Table 3). As it can be seen, the S was one 
order of magnitude higher for films than for fibers. Ford PLA films, the S  values displayed 
in Table 3 are in good agreement with those reported in the literature, which range from 35.1 
to 50 mJ·m
-2
 (up to 50 m J·m
-2
), with d
S  ca. 26.9-29.7 mJ·m
-2
, and p
S  ca. 8.2-10.5 mJ·m
-2
 
[45].
 
Similarly, the SE values of PLA–P3TMA interfaces and, therefore, their wetting 
response, are influenced by their morphology. 
The highest work of adhesion (WA), calculated using the results derived from the OWRK 
model, was obtained for PLA scaffolds, which was attributed to the fact that PLA exhibits 
the highest S (Table 2). Accordingly, this surface is less repellent to liquid than systems 
with CP. In conclusion, the SE and WA of PLA–P3TMA fibrous scaffolds prepared by 
electrospinning are substantially lower than those obtained for film. Thus, the surface of the 
fibers is more repellent to polar liquids than that of films.  
 
3.3. Electrochemical impedance spectroscopy 
The presence of the CP in the PLA fiber mat serves to meet two purposes. First, as it was 
discussed in the previous section, a small amount of adequately dispersed P3TMA is able to 
reduce the SE parameters, thus decreasing the wetting behavior and slowing down the rapid 
16 
 
drug release in polar solvents. Second, it is expected that cells will respond to an external 
electrical or electrochemical stimuli when in contact with the CP. Therefore, before drug-
loading, the bulk conductivity of PLA–P3TMA fiber mats was evaluated by EIS. Samples 
were prepared by electrospinning and cut in disc-shaped formats for adaptation to the 
capacitor cell [35]. As it is illustrated in Figure 4, scaffolds become darker with increasing 
content of CP. 
The Nyquist and Bode plots provide information about the distribution of the CP in the 
biopolymeric matrix. Figure 5a indicates that PLA and 5:1 PLA–P3TMA scaffolds exhibit 
similar resistance and capacitance, indicating that the incorporation of a low concentration 
of CP does not alter the electrochemical properties of PLA fibers. Results for the three 
replicated samples of each system were alike and, therefore, only one curve was represented. 
Spectra show a very compressed and very small beginning of a semicircle in the high 
frequency range, and an inclined straight line in the low frequency range. It is well known 
that the high frequency semicircle is associated to the bulk relaxation of the film and its 
irregular thickness and morphology, while the straight line refers to the migration of ions 
and the surface in-homogeneity of the electrodes [46]. 
On the other hand, spectra for the 1:1 PLA–P3TMA scaffolds, which contain the highest 
P3TMA concentration, show a slightly different behavior as it is observed in the 
corresponding Bode plot (Figure 5b). The phase angle for samples with such composition is 
very low in the high frequency region, which only can be explained by the presence of 
defects caused by an irregular distribution of P3TMA aggregates inside the fibers. Such 
distribution favors the rapid penetration and conduction of the electrolyte across the 
scaffold. In contrast, P3TMA seems to be homogeneously distributed in 2:1 PLA–P3TMA 
fibers showing a Nyquist plot with the lowest resistance and capacitance values (Figure 5a), 
whereas the Bode plot (Figure 5b) presents the highest phase angle (32.1º) and the lowest 
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log |Z| (1.15) at the high frequencies zone (10
5
 Hz). Quantitative analyses of these results 
required fitting with an adequate electrical equivalent circuit (EEC) for each system (Figure 
6).  
In our experiments, a PLA–P3TMA film was placed between two stainless steel (SS) 
electrodes forming through-plane cell geometry for bulk resistance and capacitance 
measurements across the film, i.e. forming a capacitor cell [35]. This means that, under 
polarization, an electrical double layer will be formed at the electrodes interface. This 
charged ion monolayer includes the electrolyte ions arranged in a monolayer at the electrode 
surface since they cannot trespass the electrode and the layer of opposite ionic charge at the 
electrode surface [46]. As it was carefully explained by Soboleva et. al. [47], the idealized 
circuit for such a system has several elements and can be represented by the EEC displayed 
in Figure 6a. Briefly, each film/blocking electrode interface is represented by the parallel 
combination of a capacitance, which models the capacitance of the double layer (C1 and C2), 
and the resistance of the blocking electrode (R1 and R2). Besides, the bulk properties of the 
polymer film are represented by means of a bulk membrane capacitance (Cb) and a bulk 
resistance (Rb). However, the above circuit can be simplified into the one shown in Figure 
6b by taking into account the following considerations: (i) the electrode/electrolyte interface 
is merely capacitive, therefore resistances R1 and R2 can be omitted; and (ii) the dominant 
process at the proton conducting electrode can be considered as a double layer capacitance.
3
 
The elements of this equivalent electric circuit are the Cdl, which models the interfacial 
capacitance that arises from the double layer capacitance at the film/electrode interface, and 
Rb and Cb, associated in parallel, which represent the bulk resistance and the geometrical 
capacitance of the film/electrode interface, respectively.  
As the real system is much more complicated and the capacitance at solid electrodes does 
not behave ideally, two constant phase elements substitute the capacitors Cdl and Cb 
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considering the in-homogeneity of the system and the roughness and irregularities of the 
electrode surface [48,49]. After fitting the experimental data to an equivalent electrical 
circuit it was found that PLA and PLA–P3TMA blends of wt.% ratio 5:1 and 2:1 adjust to 
the circuit depicted in Figure 6c while the fitting of a circuit to the 1:1 blend was much more 
difficult to achieve. This has been attributed to the fact that the high concentration of CP in 
the 1:1 film provokes the formation of P3TMA agglomerates inside the polymer matrix, 
resulting in a complex interface distribution. Thus, only the experimental data of one tested 
sample was properly fitted with the previous circuit. Therefore, in terms of the equivalent 
circuit elements analysis, the values displayed in Table 4 for the 1:1 blend are not averages. 
The electrical equivalent circuit used for the fitting of PLA and PLA–P3TMA EIS data was: 
Rsoln(RbCPE1)CPE2. It only differs from the general circuit described above (Figure 6b) in 
the presence of Rsoln, which models the PBS electrolyte resistance. The parallel combination 
of Rb and CPE1 results in the high frequency semicircle while the CPE2 represents de double 
layer capacitance. The mean of the simulated values for the EIS data are summarized in 
Table 4. The CPE impedance can be expressed as is indicated in Equations (1) and (2):  
n
CPE jBZ
 )(     (1) 
2
)1(

 n    (2) 
where B = Cd
-1
 only when n=1, and n is related to α which is the deviation from the vertical 
of the line in the Nyquist plot. Thus, n = 1 equals an ideal capacitance, and lower n values 
reflect the roughness of the electrode employed [46]. 
The EIS results showed that the density of the charge carriers and their mobility increase 
with the P3TMA content in the scaffold, improving the bulk conductivity. More specifically, 
the bulk conductivity of the fiber matrix films can be calculated by applying the Equation 
(3):  
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 = 
A
d
Rb
·
1
   (3) 
where δ is the bulk conductivity, d is the thickness of the fiber film, A is the area of the 
polymer discs and Rb is the bulk resistance.  
The good dispersion of P3TMA particles in the polymer matrix, under electrospinning 
conditions, is critical to obtain good electrical properties in the isolating fiber blends. Table 
5 lists the bulk conductivity for all examined system. Comparison of the results obtained for 
2:1 PLA-P3TMA and PLA indicates that the incorporation of 33 wt.% of P3TMA into the 
fibers composition increases the bulk conductivity by 91%. According to these results, 2:1 
PLA–P3TMA fiber mats were chosen for drug-loading and release assays since they 
accomplish the two-fold characteristic described before: good wettability and the highest 
bulk conductivity (8.26  10-7 S·cm-1). 
Bulk conductivities were recently reported for other biodegradable polymer–CP blended 
systems. For example, the electrical conductivity of electrospun fibers made of PLA blended 
with undoped polyaniline (PLA–PAni) and with polyaniline doped with camphorsulfonic 
acid (PLA–PAni·CSA) was reported to be 1.5  10-5 and 8.4  10-2 S·cm-1, respectively [50]. 
Also, McKeon et al. electrospun several polyaniline and poly(D,L-lactide) (PANi/PDLA) 
mixtures using different weight percent values. The electrical conductivity of the 75/25 
electrospun scaffold, which was the only able to conduct a current of 5 mA, was 4.37×10
-2
 
S·cm
-1
 [51]. In another work, PAni·CSA was blended with poly(L-lactide-co--
caprolactone) (PLCL) to obtain uniform nanofibers with good electrical properties [52]. 
Recently, incorporation of PANi into polycaprolactone (PCL) fibers significantly increased 
the electrical conductivity from a non-detectable level for the PCL fibers to 63.6 × 10
-3
 ± 6.6 
× 10
-3
 S·cm
-1
 for the fibers containing 3 wt.% PAni [53]. Forciniti et al. suggested than 
blends of poly(lactic-co-glycolic acid) and chloride-doped PPy exhibit the same electrical 
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properties that the individual CP [54]. Conductive PPy coating polyamide 6 (PA6) 
nanofibers were prepared by polymerizing pyrrole monomers directly onto the fiber [55].  
 
3.4. PLA-P3TMA fibers loaded with drugs 
Once the PLA–P3TMA-drug (2:1:0.4 w/w) samples were prepared considering CIP 
(antibiotic), CHX and TCS (biocides), and IBU (anti-inflammatory), SEM micrographs were 
taken to identify the possible morphological changes induced by the loading process. The 
surface of the loaded fibers was found to be less smooth and homogeneous than those of 
unloaded fiber samples. The lack of uniformity is reflected in Figures 7a and 7b for IBU and 
CIP drug loaded fibers, respectively, exhibiting enhanced flexibility and non-homogeneous 
diameters (i.e. varying from 1.58 to 5.09 µm) with respect to unloaded PLA–P3TMA. 
Besides, fibers tend to agglomerate without directional preference forming disorganized 
branches with diameters between 11 and 40 µm. Furthermore, the porosity of IBU loaded 
fibers is very high in both outside and inside, as is reflected in the micrographs of the 
interior of broken morphologies (Figure 7a, right). Figure 7b (right), which displays a PLA–
P3TMA-CIP fiber, allows us to distinguish embedded drug particles. 
Morphological changes are less severe for CHX loaded samples than for IBU- and CIP-
containing ones. Thus, well-formed and homogeneous scaffolds made of fibers with 
morphology, diameter and surface roughness similar to the unloaded ones are obtained 
(Figure 7c). Finally, TCS-containing samples provide the most homogenous fibers, 
exhibiting a highly smooth surface that largely resembles the texture of unloaded 2:1 PLA–
P3TMA fibers (Figure 7d). In spite of this, AFM images displayed in Figure 8 evidences 
that TCS provokes a drastic change in the shape of the fibers. Thus, compact and regular 
PLA–P3TMA–TCS fibers present a ribbon-like shape rather than a tubular shape like that 
observed for 2:1 PLA–P3TMA fibers (Figure 1c). Variations in the fiber texture with respect 
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to PLA–P3TMA are reflected in the AFM images of PLA–P3TMA–CHX, PLA–P3TMA–
CIP and PLA–P3TMA–IBU, which are displayed in Figure 9. The different effects of loaded 
drugs into fiber dimensions have been attributed to the changes induced by drug···drug, 
drug···PLA and drug···P3TMA interactions, which alter the polymer···polymer interactions 
established in unloaded fibers. Thus, attractive and repulsive interactions may provoke the 
collapse and expansion of the polymeric matrix, respectively. Similarly, the balance between 
the different interactions is expected to affect the texture and roughness of the fibers.  
On the other hand, considering the homogeneity of the electrospinning media, which 
were obtaining by adding the drug dissolved in DMSO to a chloroform-acetone mixture 
containing the two polymers, and the fact SEM and AFM micrographs indicate that the 
drugs were not located outside the fibers, the drug loading efficiency is considered to be 
very high in all cases. 
Confocal Raman spectroscopy was also used to examine the drug-loading into the PLA–
P3TMA samples. Figure 10, which shows the spectrum for the PLA–P3TMA–CIP samples, 
reflects the presence of several peaks (brown-shadowed) coming from the drug and the main 
absorption band from P3TMA at about 1480 cm
-1
. The corresponding optical image displays 
a white shine along the fiber that has been attributed to the drug. Unfortunately, 
identification of the loaded drug was less clear for the other three cases (not shown; 
available upon request to the authors), which has been attributed to its small concentration 
(12 wt. %).  
 
3.5. Drug release study 
Drug release from electrospun fibers in a given medium usually relates to: (i) the 
morphology and crystallinity of such fibers; and (ii) the intermolecular interactions 
established between the drugs and the polymeric matrix. Within this context, it should be 
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noted that the crystallinity and thermal behavior of PLA–P3TMA fibers was previously 
examined [33]. Quantitative release studies were performed considering PLA–P3TMA 
matrices loaded with CIP, CHX, TCS and IBU. Both PBS and PBS-EtOH were used as 
release media. According to previous studies [36], the ethanol supplement facilitates the 
delivery of highly hydrophobic molecules, such as TCS and IBU, precluding the 
establishment of early equilibrium conditions that limit their release in PBS. Figure 11a 
shows the release profiles in PBS for all four drugs loaded in PLA–P3TMA. The lower 
values were obtained for TCS (30%) and IBU (25%), suggesting that the retention into the 
polymer crystalline domains was higher for these drugs than for CIP and CHX. However, 
the release of TCS and IBU increases to 90% and 80%, respectively, when the delivery was 
performed using the more hydrophobic PBS-EtOH environment (Figure 11b).  
On the other hand, release percentages in PBS of CIP and CHX from loaded PLA–
P3TMA (i.e. 90% and 70%, respectively) are higher than those obtained for TCS and 
IBU. Furthermore, the release of CHX in PBS-EtOH was also very fast, reaching a value of 
70% after only seven hours of exposure (Figure 11b). Previous studies [56-58] indicated 
that the release kinetics of these drugs can be explained by the Higuchi and first-order 
models, which are usually combined to describe the first (from the beginning to 60%) and 
second (40-100%) stages of the release [59], respectively. In both cases, the delivery process 
is explained by the diffusion of the drug through the polymer matrix, which is facilitated by 
the ethanol-induced swelling of PLA [36]. 
Accordingly, the release profiles of CIP, CHX, TCS and IBU drugs loaded in the PLA–
P3TMA scaffolds allowed us to reach some important conclusions: a) the electrospun hybrid 
fibers of PLA and P3TMA can be successfully used to load either hydrophilic and 
hydrophobic drugs; and b) the behavior of loaded 2:1 PLA–P3TMA fibers depends on the 
release environment, drug release being faster in a more hydrophobic medium. 
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Evaluation of bactericide activity of 2:1 PLA–P3TMA–drug scaffolds 
Agar diffusion tests were conducted to demonstrate qualitatively the biological activity of 
the antimicrobial drugs (CIP, CHX and TCS) loaded into 2:1 PLA–P3TMA electrospun 
fibers (Figure 12). E. coli and S. epidermidis bacteria were chosen as representative Gram 
negative and Gram positive bacteria groups, respectively. There was no inhibition halo in 
the growth plate of E. coli and S. epidermidis (Figures 12a and 12b, respectively) around the 
unloaded and IBU-loaded PLA–P3TMA samples. This expected result is consistent with the 
lack of bactericidal activity of PLA, P3TMA and IBU. 
In contrast, halos of inhibition were observed for PLA–P3TMA electrospun fibers loaded 
with TCS, CHX and CIP, evidencing the antimicrobial activity of these drugs [36,51,57]. 
The formation of such halos corresponds to the drug released from the scaffold and, 
subsequently, diffused through the agar. The diameters of the three halos displayed in in 
Figure 12b are similar, suggesting that the susceptibility of S. epidermidis towards TCS, 
CHX and CIP is similar. However, the response of E. coli towards such drugs is completely 
different, as it is reflected by the different sizes of the halos in Figure 12a. Although the agar 
diffusion test can also be used as a quantitative method, the diameter of the halos is only 
indicative of bacterial susceptibility towards the drug. In summary, these results clearly 
prove that the biological activity of the drugs is not affected by the electrospinning process 
or by the formation of interactions between the drugs and the PLA–P3TMA matrix.  
 
4. CONCLUSIONS 
Fibers made of PLA and P3TMA, a biopolymer and a CP, respectively, have been 
prepared by electrospinning and, subsequently, characterized. The first step consisted in the 
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optimization of the electrospinning parameters, surface and conducting properties of fibers 
prepared using 5:1, 2:1 and 1:1 PLA–P3TMA compositions being examined. After this, 
fibers were loaded with different drugs and both their release and activity were studied.  
Our results demonstrate that the incorporation of P3TMA into PLA scaffolds provokes 
changes in the surface morphology and decreases the bulk resistance. Fibers prepared using 
2:1 PLA–P3TMA exhibited an increment in the bulk conductivity of 90% in comparison to 
PLA. The observed semiconducting behavior suggests that scaffolds prepared using such 
composition would be appropriated for the development of electrically stimulated drug-
delivery systems. Furthermore, wettability measurements prove that P3TMA reduces the 
surface energy parameters of PLA. This has been shown to improve the applicability of the 
prepared fibers as drug delivery systems. 
Drug release experiments in PBS and PBS-EtOH with 2:1 PLA–P3TMA–drug scaffolds 
proved that the release kinetics depends on the hydrophilicity of solution medium, being 
faster for the least hydrophilic medium. Moreover, CHX showed a stable release behavior 
either in PBS or in PBS-EtOH solutions (65-70%), combined with a good fiber formation by 
electrospinning. As it was expected, unloaded fibers (blank samples) do not show 
antibacterial activity against E. coli and S. epidermidis bacteria. However, PLA–P3TMA 
electrospun matrices loaded with TCS, CHX and CIP drugs showed normal activity against 
such two bacteria, proving that the bioactivity of these rugs was not altered by the 
electrospinning process. Overall, these results demonstrate that the drugs they are well 
mixed in the PLA–P3TMA scaffold matrices. Future work is oriented towards the release of 
drugs loaded on PLA–CP fibers by electro stimulation.  
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Table 1. Static contact angle values (in degrees) for PLA and PLA–P3TMA scaffolds prepared by electrospinning and for films obtained by 
solvent casting, respectively. 
Composition 
Water 
a) 
Formamide
 
Ethylene Glycol
 
Scaffolds
 
Solvent casting 
b) 
Scaffolds
 
Solvent casting 
b) 
Scaffolds
 
Solvent casting 
b) 
PLA 132.0 ± 2.2 76.1 ± 3.1 121.8 ± 5.4 55.3 ± 2.2 110.5 ± 2.7 50.0 ± 2.4 
PLA–P3TMA 5:1 130.5 ± 2.1 90.5 ± 3.4 118.7 ± 3.2 56.0 ± 2.3 123.8 ± 3.8 55.8 ± 2.1 
PLA–P3TMA 2:1 135.3 ± 1.5 86.9 ± 5.2 121.6 ± 4.7 55.4 ± 3.2 130.1 ± 2.0 55.0 ± 3.4 
PLA–P3TMA 1:1 134.6 ± 2.4 87.7 ± 3.8 127.4 ± 2.4 68.6 ± 5.6 126.7 ± 2.0 54.9 ± 1.6 
a) 
Taken from reference 33. 
b) 
PLA and PLA–P3TMA films were solvent casted from a solution of 16 mg·mL-1 of polymer in CHCl3 solvent. 
Mean values correspond to the average of at least 14 droplets of water, formamide and ethylene glycol. 
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Table 2. Surface energy parameters and WA values (mJ·m
-2
) for PLA–P3TMA scaffold samples. 
 
 
EoS Fowkes OWRK Work of Adhesion
a) (WA) 
 S 
d
S  
d
S  
p
S  S Water Formamide Ethylene Glycol 
PLA 7.07 ± 0.26 7.09 ± 0.23 10.99 ± 0.00 0.62 ± 0.00 11.61 ± 0.00 49.08 49.02 44.72 
PLA–P3TMA 5:1 6.53 ± 0.36 5.05 ± 0.21 3.95 ± 0.00 0.11 ± 0.00 4.06 ± 0.00 34.68 33.18 30.23 
PLA–P3TMA 2:1 5.02 ± 0.38 3.51 ± 0.28 3.61 ± 0.00 0.00 ± 0.00 3.62 ± 0.00 33.72 33.13 29.26 
PLA–P3TMA 1:1 4.43 ± 0.18 3.61 ± 0.14 2.52 ± 0.00 0.13 ± 0.00 2.65 ± 0.00 30.37 28.45 25.91 
a) 
WA values for PLA–P3TMA scaffolds based on data derived from the OWRK model. 
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Table 3. Surface energy parameters of the PLA and the PLA-P3TMA samples prepared by 
solvent casting. 
 
 EoS Fowkes  OWRK  
PLA-P3TMA 𝛾𝑆 𝛾𝑆
𝑑 𝛾𝑆
𝑑 𝛾𝑆
𝑝
 𝛾𝑆 
1:0 37.65 ± 0.24 35.99 ± 0.02 33.99 ± 0.03 4.42 ± 0.01 38.41 ± 0.03 
5:1 33.79 ± 0.77 53.67 ± 0.10 73.08 ± 0.00 2.31 ± 0.01  75.39 ± 0.00 
2:1 34.75 ± 0.69 54.6 ± 0.10 58.2 ± 0.02 0.10 ± 0.00  58.31 ± 0.02 
1:1 32.04 ± 0.38 47.93 ± 0.10 37.66 ± 0.02 0.95 ± 0.00 39.62 ± 0.02 
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Table 4. Thickness and bulk conductivity values for the PLA-P3TMA fiber scaffolds 
obtained by EIS measurements. 
 
# Thickness (µm)  (10
-7 S·cm-1) 
PLA 18.9 ± 4.2 4.33 ± 0.91 a) 
PLA–P3TMA 5:1 26.0 ± 5.9 5.39 ± 0.72 
a)
 
PLA–P3TMA 2:1 25.2 ± 10.6 8.26 ± 0.59 
a)
 
PLA–P3TMA 1:1 24.8 ± 5.8 8.16 
 b)
 
a)
 Average of three independent samples fitted to the proposed 
electrical equivalent circuit (EEC). 
b)
  Only one sample fitted 
properly to the proposed EEC. 
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Table 5. Data of EIS results obtained from the electrical equivalent circuit showed in the Figure 6 for all polymeric blends. 
 
PLA-P3TMA Rsol (Ω) CPE1 (F s
n−1) n1 Rb (kΩ) CPE2 (F s
n−1) n2 
1:0 8.24 ± 3.34    5.0010-5 ± 1.71 x10-5 0.50 ± 0.08 2.47 ±  0.09 2.2710-5  ± 1.82 10-5 0.73 ±  0.13 
5:1 11.73 ± 3.91 1.5510-4  ±  3.02x10-5 0.51 ±  0.02 2.74 ± 0.54 4.2110-5  ±  1.9010-6 0.87 ± 0.03 
2:1 11.62 ±  5.58 1.4710-4 ±  5.76 x10-5 0.50 ± 0.03 1.75 ±  0.82 1.5110-5 ± 8.8310-6 0.73 ± 0.05 
1:1a) 939 1.3210-5 0.66 1.456 4.8810-6 0.80 
a) 
Only one sample properly fitted to the equivalent circuit proposed. 
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FIGURE CAPTIONS 
Figure 1. AFM micrographs from PLA and PLA–P3TMA fibers scaffolds prepared by 
electrospinning: (a) PLA, (b) 5:1 PLA–P3TMA, (c) 2:1 PLA–P3TMA and (d) 1:1 PLA–
P3TMA. 
Figure 2. (a) PLA fiber optical image. (b) PLA Raman spectra at the cross point from (a). 
(c) PLA–P3TMA (2:1) fiber optical image. (d) Raman spectra at the cross points from (b). 
The solid black line corresponds to the white cross in (c) and the discontinued line to 
powder P3TMA. (e) PLA–P3TMA (2:1) fiber optical image. Inset: scanned area (red box). 
(f) Raman spectra associated to the inset in (e).  
Figure 3. Expected wetting behavior of PLA-P3TMA scaffold samples where air pockets 
avoid the liquid infiltration. 
Figure 4. Photographs of PLA–P3TMA and PLA electrospun fibers and PLA saolvent 
casted films prepared for EIS analyses using a capacitor cell.  
Figure 5. a) Nyquist plots of PLA (square) and 5:1, 2:1 and 1:1 PLA–P3TMA (diamond, 
round and triangle, respectively) fiber matrices obtained using a capacitor cell. The inset in 
the diagram shows the impedance plot with magnified scale axes. Continuous lines 
correspond to the fitting of results obtained using the EC to the experimental data. b) Bode 
diagram from Nyquist plot. Filled figures refer to the angle phase axis while empty figures 
refer to the log|Z| axis. 
Figure 6. Equivalent electrical circuit for the scaffold films between two blocking 
electrodes: (a) Idealized circuit, (b) Simplified circuit and (c) electrical equivalent circuit of 
P3TMA:PLA system. HF stands for High Frequency range and LF for Low Frequency 
range. 
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Figure 7. SEM images of 2:1 PLA–P3TMA fibers loaded with: (a) IBU, (b) CIP, (c) 
CHX and (d) TCS. Left and right images correspond to small and high magnifications. 
Figure 8. AFM micrographs from PLA–P3TMA–TCS fibers: (a) 2D height image, (b) 
3D image (1010 µm2) and (c) SEM micrograph (scale bar: 4 µm). 
Figure 9 AFM micrographs from PLA:P3TMA 2:1 loaded with CHX (top), IBU 
(middle) and CIP (bottom): 2D height image, 3D images and SEM micrograph. 
Figure 10. (a) Optical image of PLA–P3TMA–CIP fibers. The red line shows the spot in 
which the Raman spectrum was taken. (b) Raman spectra: the dotted line corresponds to 
P3TMA powder, the blue line to CIP powder and the red line to the PLA–P3TMA–CIP 
sample. Peaks coming from the drug are brown-shadowed. 
Figure 11. Drug release profile from 2:1 PLA–P3TMA scaffolds in (a) PBS (a) and (b) 
PBS-EtOH. 
 
Figure 12. Inhibition of bacteria growth for (a) Escherichia coli and (b) Staphylococcus 
epidermidis. Unloaded 2:1 PLA–P3TMA scaffold was used as control disk. TCS, CHX, CIP 
and IBU disks refer to 2:1 PLA–P3TMA fibers loaded with the corresponding drug. Red 
lines indicate the areas of the plates occupied by each samples. The inhibition zones are 
highlighted with dotted lines. 
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